Studies concluded that inactivated COVID‐19 vaccines do not increase the risk of thrombosis. This report presents a 23‐year‐old man with the chief complaint of severe pain, swelling, and erythema of the right upper extremity following his second dose of the Sinopharm vaccine. Duplex...
One elderly participant, having experienced pain with the HW-administered swab, was reluctant to take part again. Five main themes were identified related to motivation to participate in the study: sense of contribution; self-benefits; perceived effort of taking part; influence from others; and ...
1. 语法填空 China is now fighting a war of a different kind. It's against unseen enemy, which has been named COVID-19 by the WHO. Since its appearance at the end of December in Wuhan, the virus causing this disease (spread) to other cities, infecting hundreds of thousands of people ...
However, after a booster dose with the mRNA-1273 (Moderna) vaccine, the patient developed a high fever persisting for one week after the shot, and sequential severe swelling, inflammation, and pain in the contralateral arm lasting for three weeks....
We describe a case of an otherwise healthy 60‐year‐old female patient who presented 6 days after receipt of the second dose of the BNT162b2 mRNA COVID‐19 (Pfizer/BioNTech) vaccine and was found to have upper extremity deep venous thrombosis.Gonzalez, Susan...
Rujittika MungmunpuntipantipPrivate Academic Consultant, Bangkok Thailand rujittika@gmail.comViroj WiwanitkitUniversity Centre for Research & Development Department of Pharmaceutical Sciences, Chandigarh University Gharuan, Mohali, Punjab, India.Lippincott Williams & WilkinsClinical Nuclear Medicine...
Infection breakthrough after COVID-19 vaccination is a point of conflict in current literature not only because of the estimation of the potential hazards and symptoms severity but also due to establishing a vaccination policy and measuring the extent of immunity after vaccination in addition to the...
Blood samples before and after consuming probiotics/placebo were drawn from the participants in the first arm (winter season of 2020–2021). Participants with markedly abnormal results of blood tests were excluded. The nutritional assessment of the participants was based on the full version of the...
vaccine [69]. Athletes performing moderate- to low-intensity exercise training do not need to reduce exercise intensity [69]. It has been found that nearly 94% of athletes experience arm pain, general fatigue, and fever after receiving the vaccine for 2 days [70]. Therefore, it can be ...